This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Akam Salih
Senior Scientist in Radiopharmacology at Mariana Oncology
Speaker

Profile

Akam Salih is a Senior Scientist in Radiopharmacology at Mariana Oncology, where he leads the preclinical radiochemistry team focused on the discovery and development of precision radiopharmaceuticals for cancer therapy. He earned his Master’s degree in Cancer Chemistry from the University of Leicester, England, and his Ph.D. in Organic Chemistry and Radiochemistry from the University of Saskatchewan, Canada, where his research centered on the design and synthesis of novel chelators for radiometal-based imaging and therapeutic agents.

Agenda Sessions

  • Discovery of 225Ac-ETN029: A Peptide-based Radioligand Therapy for the Treatment of DLL3-expressing Solid Tumors

    5:15pm